title: Viral hepatitis in the Arctic. A review from a Circumpolar Workshop on Viral hepatitis, ICCH13.
abstract: This article is a review of the viral hepatitis workshop, held during the 13th International Congress of the Circumpolar Health consists of a review of data on viral hepatitis in the Arctic territories of four countries: Canada, Greenland, Russia and United States (Alaska). The main purpose of the workshop was to exchange knowledge on viral hepatitis in the Arctic and identify further needs for collaborative hepatitis research, which is planned to be implemented through the established Viral Hepatitis Working Group in the Arctic. The review is based on the available published research results, surveillance data and professional opinions of the authors. The information is presented by Arctic country. Viral hepatitis constitutes an important problem among Aboriginal peoples of the Arctic; the incidence of most types of viral hepatitis is higher among indigenous populations than in the general public. However, due to differences in the available information from each of the four Arctic countries, it is difficult to compare differences in types of disease in them. The main areas for future research are: HBV genotypes distribution, relations between different types of HBV, HCV and disease outcomes, HBV mutation rate and specific substitutions in the HBV genome over time in the Arctic, and occurrence of active liver disease in HBsAg carriers living in the Arctic, as well as further research in viral hepatitis A, C, D and E.
authors.affiliation: Northern State Medical University, Arkhangelsk, Russia. tandr@atnet.ru
authors.forename: Andrei
authors.initials: A
authors.lastname: Tulisov
authors.forename: Brian J
authors.initials: BJ
authors.lastname: McMahon
authors.forename: Anders
authors.initials: A
authors.lastname: Koch
authors.forename: Gerald
authors.initials: G
authors.lastname: Minuk
authors.forename: Vladimir
authors.initials: V
authors.lastname: Chulanov
authors.forename: Michael G
authors.initials: MG
authors.lastname: Bruce
authors.forename: Julia
authors.initials: J
authors.lastname: Uhanova
authors.forename: Malene
authors.initials: M
authors.lastname: Børresen
authors.forename: James
authors.initials: J
authors.lastname: Williams
authors.forename: Carla
authors.initials: C
authors.lastname: Osiowy
authors.forename: Allan
authors.initials: A
authors.lastname: Gelvan
authors.forename: Marfa
authors.initials: M
authors.lastname: Alexeeva
authors.forename: Bryce
authors.initials: B
authors.lastname: Larke
authors.forename: Kymberly
authors.initials: K
authors.lastname: Watt
mesh_terms: D000413:Alaska / Q000453:epidemiology; D001110:Arctic Regions / Q000453:epidemiology; D002170:Canada / Q000453:epidemiology; D003081:Cold Climate; D004493:Education; D005838:Genotype; D006116:Greenland / Q000453:epidemiology; D006521:Hepatitis, Chronic / Q000453:epidemiology* / Q000235:genetics; D006525:Hepatitis, Viral, Human / Q000453:epidemiology* / Q000235:genetics / Q000635:transmission; D006801:Humans; D044382:Population Groups; D011159:Population Surveillance; D015995:Prevalence; D012307:Risk Factors; D014761:Viral Hepatitis Vaccines
chemical_list: D014761:Viral Hepatitis Vaccines